CG
Column Group Opportunity III, LP disclosed a 21.6% stake in TNYA
Column Group Opportunity III, LP reported owning 21.6% of Tenaya Therapeutics, Inc. (TNYA) (49,313,559 shares) in a Schedule 13D filed Nov 16, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13D